The Research and Development team at Aviceda Therapeutics is dedicated to advancing innovative therapies by exploring glycobiology's potential to modulate the innate immune system. This multidisciplinary group conducts cutting-edge research, formulates drug candidates, and manages laboratory operations to develop next-generation immuno-modulators aimed at resolving chronic inflammation, with a particular focus on neurological conditions.